GetTopicDetailResponse(id=38a4e8386f4, topicName=經(jīng)皮冠狀動(dòng)脈介入, introduction=經(jīng)皮冠狀動(dòng)脈介入, content=null, image=null, comments=1, allHits=2069, url=https://h5.medsci.cn/topic?id=78386, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=17821, tagList=[TagDto(tagId=17821, tagName=經(jīng)皮冠狀動(dòng)脈介入)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1003655, encodeId=5f5e100365530, content=<a href='/topic/show?id=38a4e8386f4' target=_blank style='color:#2F92EE;'>#經(jīng)皮冠狀動(dòng)脈介入#</a>即<a href='/topic/show?id=36d313833c9' target=_blank style='color:#2F92EE;'>#PCI#</a>導(dǎo)致的出血，與很多因素有關(guān)，如術(shù)后的雙抗使用，如<a href='/topic/show?id=51639e734cb' target=_blank style='color:#2F92EE;'>#阿司匹林#</a>，<a href='/topic/show?id=5a626408e66' target=_blank style='color:#2F92EE;'>#氯吡格雷#</a>或<a href='/topic/show?id=43666034930' target=_blank style='color:#2F92EE;'>#替格瑞洛#</a>，以及不同人的出血風(fēng)險(xiǎn)的評(píng)估等, objectTitle=JAHA：經(jīng)皮冠狀動(dòng)脈介入術(shù)后顱內(nèi)出血的發(fā)生率、預(yù)測(cè)因素和對(duì)死亡率的影響, objectType=article, longId=215051, objectId=fdb8215051e0, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2021729/1627561256921_1739456.jpeg, objectUrl=/article/show_article.do?id=fdb8215051e0, replyNumber=0, likeNumber=422, createdTime=2021-07-29, rootId=0, userName=小小醫(yī)者, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fdb8215051e0, moduleTitle=JAHA：經(jīng)皮冠狀動(dòng)脈介入術(shù)后顱內(nèi)出血的發(fā)生率、預(yù)測(cè)因素和對(duì)死亡率的影響, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=fdb8215051e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
